skip to content

Broker Views

Broker Forecast - Stifel issues a broker note on Circassia Pharmaceuticals Plc

20 March 2017 11:30

Stifel today upgrades its investment rating on Circassia Pharmaceuticals Plc (LON:CIR) to buy (from hold) and raised its price target to 150p (from 99p).

Story provided by StockMarketWire.com

Related Company: CIR

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

aew-banner-180x255.jpg

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.